Results: 1-25 | 26-45
Results: 1-25/45

Authors: Monforte, AD Bugarini, R Pezzotti, P De Luca, A Antinori, A Mussini, C Vigevani, GM Tirelli, U Bruno, R Gritti, F Piazza, M Chigiotti, S Chirianni, A De Stefano, C Pizzigallo, E Perrella, O Moroni, M
Citation: Ad. Monforte et al., Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAART, J ACQ IMM D, 28(2), 2001, pp. 114-123

Authors: Tozzi, V Balestra, T Galgani, S Narciso, P Sampaolesi, A Antinori, A Giulianelli, M Serraino, I Ippolito, G
Citation: V. Tozzi et al., Changes in neurocognitive performance in a cohort of patients treated withHAART for 3 years, J ACQ IMM D, 28(1), 2001, pp. 19-27

Authors: Murri, R Ammassari, A Pezzotti, P Cingolani, A De Luca, A Pallavicini, F Grillo, R Antinori, A
Citation: R. Murri et al., Incidence and determinants of bacterial infections in HIV-positive patients receiving anti-Pneumocystis carinii/Toxoplasma gondii primary prophylaxiswithin a randomized clinical trial, J ACQ IMM D, 27(1), 2001, pp. 49-55

Authors: Girardi, E Palmieri, F Cingolani, A Ammassari, A Petrosillo, N Gillini, L Zinzi, D De Luca, A Antinori, A Ippolito, G
Citation: E. Girardi et al., Changing clinical presentation and survival in HIV-associated tuberculosisafter highly active antiretroviral therapy, J ACQ IMM D, 26(4), 2001, pp. 326-331

Authors: Antinori, A Ammassari, A Giancola, ML Cingolani, A Grisetti, S Murri, R Alba, L Ciancio, B Soldani, F Larussa, D Ippolito, G De Luca, A
Citation: A. Antinori et al., Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era, J NEUROVIRO, 7(4), 2001, pp. 323-328

Authors: De Luca, A Giancola, ML Ammassari, A Grisetti, S Cingolani, A Larussa, D Alba, L Murri, R Ippolito, G Cauda, R Monforte, AD Antinori, A
Citation: A. De Luca et al., Potent anti-retroviral therapy with or without cidofovir for AIDS-associated progressive multifocal leukoencephalopathy: Extended follow-up of an observational study, J NEUROVIRO, 7(4), 2001, pp. 364-368

Authors: Visca, P Petrucca, A De Mori, P Festa, A Boumis, E Antinori, A Petrosillo, N
Citation: P. Visca et al., Community-acquired Acinetobacter radioresistens bacteremia in an HIV-positive patient, EM INFECT D, 7(6), 2001, pp. 1032-1035

Authors: Romagnoli, C Frezza, S Cingolani, A De Luca, A Puopolo, M De Carolis, MP Vento, G Antinori, A Tortorolo, G
Citation: C. Romagnoli et al., Plasma levels of interlenkin-6 and interleukin-10 in preterm neonates evaluated for sepsis, EUR J PED, 160(6), 2001, pp. 345-350

Authors: Lepri, AC Phillips, AN Monforte, AD Castelli, F Antinori, A de Luca, A Pezzotti, P Alberici, F Cargnel, A Grima, P Piscopo, R Prestileo, T Scalise, G Vigevani, M Moroni, M
Citation: Ac. Lepri et al., When to start highly active antiretroviral therapy in chronically HIV-infected patients: evidence from the ICONA study, AIDS, 15(8), 2001, pp. 983-990

Authors: Liuzzi, G Zaccarelli, M Sette, P Grisetti, S Alba, L Antinori, A
Citation: G. Liuzzi et al., Acute hepatitis B by sexual transmission after interruption of lamivudine-containing antiretroviral regimen, AIDS, 15(15), 2001, pp. 2062-2063

Authors: Antinori, A Cingolani, A Alba, L Ammassari, A Serraino, D Ciancio, BC Palmieri, F De Luca, A Larocca, LM Ruco, L Ippolito, G Cauda, R
Citation: A. Antinori et al., Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy, AIDS, 15(12), 2001, pp. 1483-1491

Authors: Antinori, A Baldini, F Girardi, E Cingolani, A Zaccarelli, M Di Giambenedetto, S Barracchini, A De Longis, P Murri, R Tozzi, V Ammassari, A Rizzo, MG Ippolito, G De Luca, A
Citation: A. Antinori et al., Female sex and the use of anti-allergic agents increase the risk of developing cutaneous rash associated with nevirapine therapy, AIDS, 15(12), 2001, pp. 1579-1581

Authors: Spizzichino, L Zaccarelli, M Rezza, G Ippolito, G Antinori, A Gattari, P
Citation: L. Spizzichino et al., HIV infection among foreign transsexual sex workers in Rome - Prevalence, behavior patterns, and seroconversion rates, SEX TRA DIS, 28(7), 2001, pp. 405-411

Authors: Rezza, G Zaccarelli, M Giuliani, M Calcaterra, S Garbuglia, AR Catalani, C Benvenuti, M Di Carlo, A Ippolito, G Antinori, A
Citation: G. Rezza et al., Sexual transmission of transfusion-transmitted virus, SEX TRA DIS, 28(5), 2001, pp. 298-299

Authors: Ammassari, A Antinori, A
Citation: A. Ammassari et A. Antinori, AIDS-related focal brain lesions in the era of highly active antiretroviral therapy - Reply from the authors, NEUROLOGY, 56(5), 2001, pp. 696-696

Authors: Spina, M Vaccher, E Juzbasic, S Milan, I Nasti, G Talamini, R Fasan, M Antinori, A Nigra, E Tirelli, U
Citation: M. Spina et al., Human immunodeficiency virus-related non-Hodgkin lymphoma - Activity of infusional cyclophosphamide, doxorubicin, and etoposide as second-line chemotherapy in 40 patients, CANCER, 92(1), 2001, pp. 200-206

Authors: Murri, R Ammassari, A Antinori, A
Citation: R. Murri et al., Adherence to protease inhibitors, ANN INT MED, 134(7), 2001, pp. 625-625

Authors: Murri, R Ammassari, A Gallicano, K De Luca, A Cingolani, A Jacobson, D Wu, AW Antinori, A
Citation: R. Murri et al., Patient-reported nonadherence to HAART is related to protease inhibitor levels, J ACQ IMM D, 24(2), 2000, pp. 123-128

Authors: Cingolani, A Sanguinetti, M Antinori, A Larocca, LM Ardito, F Posteraro, B Federico, G Fadda, G Ortona, L
Citation: A. Cingolani et al., Brief report: Disseminated mycobacteriosis caused by drug-resistant Mycobacterium triplex in a human immunodeficiency virus-infected patient during highly active antiretroviral therapy, CLIN INF D, 31(1), 2000, pp. 177-179

Authors: De Luca, A Giancola, ML Cingolani, A Ammassari, A Murri, R Antinori, A
Citation: A. De Luca et al., Circulating levels and ex vivo production of beta-chemokines, interferon gamma, and interleukin 2 in advanced human immunodeficiency virus type 1 infection: The effect of protease inhibitor therapy, AIDS RES H, 16(9), 2000, pp. 835-843

Authors: Cingolani, A Gastaldi, R Fassone, L Pierconti, F Giancola, ML Martini, M De Luca, A Ammassari, A Mazzone, C Pescarmona, E Gaidano, G Larocca, LM Antinori, A
Citation: A. Cingolani et al., Epstein-Barr virus infection is predictive of CNS involvement in systemic AIDS-related non-Hodgkin's lymphomas, J CL ONCOL, 18(19), 2000, pp. 3325-3330

Authors: Monforte, AD Lepri, AC Rezza, G Pezzotti, P Antinori, A Phillips, AN Angarano, G Colangeli, V De Luca, A Ippolito, G Caggese, L Soscia, F Filice, G Gritti, F Narciso, P Tirelli, U Moroni, M
Citation: Ad. Monforte et al., Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients, AIDS, 14(5), 2000, pp. 499-507

Authors: De Luca, A Giancola, ML Ammassari, A Grisetti, S Cingolani, A Paglia, MG Govoni, A Murri, R Testa, L Monforte, AD Antinori, A
Citation: A. De Luca et al., Cidofovir added to HAART improves virological and clinical outcome in AIDS-associated progressive multifocal leukoencephalopathy, AIDS, 14(14), 2000, pp. F117-F121

Authors: De Luca, A Baldini, F Cingolani, A Di Giambenedetto, S Zaccarelli, M Tozzi, V Ammassari, A Murri, R Antinori, A
Citation: A. De Luca et al., Benefits and risks of switching from protease inhibitors to nevirapine with stable background therapy in patients with low or undetectable viral load: a multicentre study, AIDS, 14(11), 2000, pp. 1655-1656

Authors: Ammassari, A Cingolani, A Pezzotti, P De Luca, A Murri, R Giancola, ML Larocca, LM Antinori, A
Citation: A. Ammassari et al., AIDS-related focal brain lesions in the era of highly active antiretroviral therapy, NEUROLOGY, 55(8), 2000, pp. 1194-1200
Risultati: 1-25 | 26-45